Gracell Biotechnologies - Ownership and Business Overview

Life ScienceCompany

Gracell Biotechnologies Ownership

Who owns Gracell Biotechnologies?

Gracell Biotechnologies is owned by AstraZeneca. It was acquired on December 26, 2023.

Gracell Biotechnologies Business Overview

Where is Gracell Biotechnologies headquartered?

Gracell Biotechnologies is headquartered in Suzhou, China.

What sector is Gracell Biotechnologies in?

Gracell Biotechnologies is a life science company.

When was Gracell Biotechnologies founded?

Gracell Biotechnologies was founded in 2017.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

Gracell Biotechnologies

Gracell Biotechnologies, Inc.

Building 12, Block B, Phase II, Biobay Industrial Park 218 Sangtian Street Suzhou Industrial Park,
Suzhou, 215123
China,
+86 512 6262 6701
www.gracellbio.com

Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. Gracell Biotechnologies was founded in 2017 and is based in Suzhou, China.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Gracell Biotechnologies

Life Science Companies , China Companies